Novelon Tablet is a combined oral contraceptive containing Ethinyl Estradiol (0.03mg) and Desogestrel (0.15mg). This pharmaceutical formulation is designed for the prevention of pregnancy in women by providing a progestogen-dominant and estrogen-low dose regimen. The regular intake of Novelon Tablets at the prescribed schedule creates a continuous low-hormone environment in the body, preventing ovulation and thickening the cervical mucus to inhibit sperm penetration, while thinning the endometrium to reduce the likelihood of implantation. It is essential to note that Novelon Tablets should be used under the supervision of a healthcare provider, and their use may be contraindicated in individuals with specific medical conditions, such as thrombophilia or breast cancer. Potential side effects include nausea, breast tenderness, headache, and breakthrough bleeding. Regular monitoring of blood pressure and lipid profiles is recommended during long-term use.